Vaxxinity, Inc. - stock earnings
VAXX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -13.1 million USD | ? USD |
| 2023Q2 | -14.0 million USD | ? USD |
| 2023Q1 | -18.4 million USD | ? USD |
| 2022Q4 | -20.5 million USD | ? USD |
| 2022Q3 | -19.2 million USD | ? USD |
| 2022Q2 | -17.3 million USD | ? USD |
| 2022Q1 | -18.3 million USD | ? USD |
| 2021Q4 | -48.2 million USD | -1000 USD |
| 2021Q3 | -30.4 million USD | 50000 USD |
| 2021Q2 | -26.9 million USD | ? USD |
| 2021Q1 | -32.0 million USD | 17000 USD |
| 2020Q4 | -12.7 million USD | ? USD |
| 2020Q3 | -16.5 million USD | 117000 USD |
| 2020Q2 | -7.1 million USD | 440000 USD |
VAXX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -66.0 million USD | ? USD |
| 2022 | -75.2 million USD | -1000 USD |
| 2021 | -138.0 million USD | 66000 USD |
| 2020 | -35.4 million USD | 557000 USD |
| 2019 | -14.2 million USD | ? USD |
VAXX
Price: $0.12
52 week price:
Earnings Per Share: -0.45 USD
P/E Ratio: -1.34
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 380403
Market Capitalization: 61.8 million